0001209191-23-047056.txt : 20230823
0001209191-23-047056.hdr.sgml : 20230823
20230823162355
ACCESSION NUMBER: 0001209191-23-047056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230821
FILED AS OF DATE: 20230823
DATE AS OF CHANGE: 20230823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wijkstrom Joakim
CENTRAL INDEX KEY: 0001785888
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34186
FILM NUMBER: 231197888
MAIL ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON, DC
STATE: DC
ZIP: 20037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001347178
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030491827
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
BUSINESS PHONE: 202-734-3400
MAIL ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-21
0
0001347178
Vanda Pharmaceuticals Inc.
VNDA
0001785888
Wijkstrom Joakim
2200 PENNSYLVANIA AVENUE
SUITE 300E
WASHINGTON
DC
20037
0
1
0
0
SVP, Chief Marketing Officer
0
Common Stock
2023-08-21
4
S
0
3724
5.84
D
113816
D
Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.
/s/ Joakim Wijkstrom
2023-08-23